Effects of Ciprofol Total Intravenous Anesthesia on Postoperative Recovery Quality in Patients Undergoing Radical Thyroidectomy for Thyroid Cancer: A Randomized, Controlled, Non-Inferiority Study
Drug Design, Development and Therapy · 2026-11 · Volume 20 · 1-10
DOI: 10.2147/dddt.s636421 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-11. Verfasst von Fangli Yue und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
This study aimed to investigate the effects of ciprofol on the quality of postoperative recovery in patients undergoing radical thyroidectomy for thyroid cancer, so as to provide a reference for clinical medication. Patients and Methods: A total of 150 patients who underwent radical thyroidectomy for thyroid cancer between December 2025 and April 2026 were randomly divided into the ciprofol group (Group C) and the propofol group (Group P). Anesthesia induction: Group C received ciprofol 0.4 mg/kg, and Group P received propofol 2 mg/kg. Anesthesia maintenance: Group C received ciprofol at 0.8– 1.25 mg/kg/h, and Group P received propofol at 4– 6 mg/kg/h. The BIS value was maintained between 40 and 60 by adjusting infusion rates. The primary outcome was the Quality of Recovery-15 (QoR-15) score on postoperative day 1 (POD 1).
Results
The total QoR-15 score on POD 1 in Group C was non-inferior to that in Group P (130.83± 18.03 vs 127.35± 18.01), with a mean difference of 3.48 (95% CI: − 2.33 to 9.29), and the lower limit of the confidence interval was greater than the non-inferiority margin of − 8. Compared with the propofol group, the ciprofol group had a lower incidence of injection pain (1.3% vs 44.0%, P=0.001) and a lower rate of vasoactive agent use (17.3% vs 41.3%, P=0.001). In addition, we found that the time to awakening and the time to extubation were longer in the ciprofol group.
Conclusion
The quality of postoperative recovery in patients undergoing thyroidectomy under ciprofol-based total intravenous anesthesia is non-inferior to that under propofol-based total intravenous anesthesia, and ciprofol may therefore serve as an alternative to propofol for total intravenous anesthesia.
Zitieren
APA
Yue, F., Ji, R., Yu, S., Yin, B., Zhang, H., Ji, F., & Xiao, H. (2026). Effects of Ciprofol Total Intravenous Anesthesia on Postoperative Recovery Quality in Patients Undergoing Radical Thyroidectomy for Thyroid Cancer: A Randomized, Controlled, Non-Inferiority Study. Drug Design, Development and Therapy, Volume 20, 1-10. https://doi.org/10.2147/dddt.s636421
Vancouver
Yue F, Ji R, Yu S, Yin B, Zhang H, Ji F, et al. Effects of Ciprofol Total Intravenous Anesthesia on Postoperative Recovery Quality in Patients Undergoing Radical Thyroidectomy for Thyroid Cancer: A Randomized, Controlled, Non-Inferiority Study. Drug Design, Development and Therapy. 2026;Volume 20:1-10. doi:10.2147/dddt.s636421
BibTeX
@article{Yue2026,
author = {Yue, Fangli and Ji, Ruoyi and Yu, Shiyu and Yin, Bingzhe and Zhang, Huan and Ji, Fanceng and Xiao, Hongyi},
title = {Effects of Ciprofol Total Intravenous Anesthesia on Postoperative Recovery Quality in Patients Undergoing Radical Thyroidectomy for Thyroid Cancer: A Randomized, Controlled, Non-Inferiority Study},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--10},
doi = {10.2147/dddt.s636421}
}
EUVIMED